Circulating Tumor Cells Market, By Technology (CTC Analysis, CTC Direct Detection Methods, and CTC Detection & Enrichment Methods), By Application (Research and Clinical/Liquid Biopsy), By Product (Devices or Systems, Blood Collection Tubes, and Kits & Reagents), By Specimen (Bone Marrow, Blood, and Other Body Fluids), and By Geography (NA, APAC, EU, LATAM, and MEA) Analysis, Size, Share, Trends, & Forecast from 2020-2026
REPORT HIGHLIGHT
Circulating tumor cells market was valued at USD 8.87 million by 2019, growing with 12.8% CAGR during the forecast period, 2020-2026.
Circulating tumor cells (CTC) are circulating inside the human body through the lymphatic and blood circulation systems. These cells are useful for understanding disease progression, detection of cancer, and projection of treatment necessary for tumor elimination. Besides, various tumor markers can be used with CTC for cancer diagnosis. CTC testing is widely used in the examination of various types of cancer such as colon cancer, prostate cancer, and breast cancer.
Market Dynamics
The growing prevalence of cancer all across the globe is the major factor boosting the growth of the global circulating tumor cells (CTC) market. According to Cancer Research UK, there were around 17 million new cases of cancer all over the world in 2018 and this number is estimated to increase up to 27.5 million by 2040. The four most common type of cancer occurring worldwide includes lung, breast, prostate, and bowel cancer. Furthermore, rising demand for efficient diagnostic & screening tests and advancements in technologies for cancer detection are the important driving factors for this industry.
However, reluctance for the adoption of technologically advanced CTC and lack of awareness amongst people are predicted to hamper the market growth in the coming future. Conversely, innovation in CTC technologies and the rising demand for faster diagnostics are expected to offer lucrative growth opportunities in the overall market during the forecast period.
Technology Takeaway
“CTC detection & enrichment methods segment to be most lucrative during the forecast period”
Based on technology, the global CTC market is categorized into CTC analysis, CTC direct detection methods, and CTC detection & enrichment methods. The CTC direct detection methods segment is further sub-categorized into microscopy and SERS. Whereas, the CTC detection & enrichment methods are further sub-categorized into combined methods, density-based separation, size-based separation, and immunocapture.
The CTC detection & enrichment methods segment accounted for the largest market share in 2019 and is anticipated to lead the market during the forecast period. This majorly owing to the high usage rates of this technology method in biotechnology research & developments, cancer detection, and high accuracy evinced by this technology. The advancements of enhanced CTCs enable their functional depiction, which is crucial for disease interrogation as well as target therapy. Thus leads to increased demand for enrichment technology. In addition, the growing preference for companion diagnostics coupled with high demand for CTC detection assays will propel the segmental market growth in the coming years.
Application Takeaway
“Clinical & liquid biopsy segment to witness significant growth by 2026”
On the basis of application, the worldwide CTC market is bifurcated into research and clinical &liquid biopsy. The research segment is further sub-categorized into drug & therapy development and cancer stem cell & tumorigenesis research. Whereas, the clinical & liquid biopsy segment is further sub-categorized into screening & monitoring and risk assessment.
The clinical & liquid biopsy segment accounted for the majority of share in the market in 2019 and is expected to grow at a significant rate during the forecast period. This is mainly because the CTC-based screening & monitoring methods are at the promising stage. However, a significant number of commercial tests of liquid biopsy are based on cf-DNA (cell-free DNA) and the dominance of cf-DNA over CTC in cancer diagnosis has hampered the clinical application share in the market. On the contrary, due to the real-time advantages and noninvasiveness of CTC screening, various research groups and companies are taking initiatives to expand the application in clinical settings for tumor cells. This will likely fuel the growth of the clinical & liquid biopsy segment in the projected timeframe.
Product Takeaway
“Devices or systems segment to hold the majority of market share in the forecast period”
Based on the product, the overall market for CTC is categorized into devices or systems, blood collection tubes, and kits & reagents. Among these, the devices or systems segment registered for the highest market share in 2019 and is anticipated to continue this trend during the period of forecast. The presence of a wide portfolio for devices and systems along with forthcoming advances in microfluidics technology are helping this segment to maintain a leading position in the market. In addition, the advancement of automated instruments that helps in eliminating the use of added blood collection tubes is propelling the segmental market growth.
On the other side, the kits & reagents segment is also estimated to contribute to a significant market share in terms of revenue owing to its high usage rate and frequent purchase rate. Moreover, various cancer cell lines have been tested by numerous researchers and a group of researchers with the help of kits offered in the space. This is mainly because these kits are easy to use and the resultant product is subsequently used in downstream analysis.
Specimen Takeaway
“Blood segment to hold the highest market share by 2026”
Based on the specimen, the worldwide market is categorized into bone marrow, blood, and other body fluids. Of these, the blood segment accounted for the largest market share in 2019 and is expected to grow at a considerable rate during the forecast period. This is mainly because a large number of CTC cells are present in blood samples as compared to other biospecimens. In cancer research, blood samples are considered important as it aids in the prophecy of prognosis and determines responsively to systemic chemotherapy. Conversely, the use of whole blood specimens poses a challenge when united with microfluidic technology.
Regional Takeaway
“North America region to dominate the industry throughout the forecast”
Depending on the region, the global industry is divided into North America, Middle East & Africa, Asia Pacific, Latin America, and Europe. The North America CTC market is projected to dominate the industry throughout the forecast owing to the presence of major industry players and the availability of noninvasive & cost-effective biomarker tests in the region. On the other hand, the Asia Pacific region is estimated to grow at a lucrative rate by 2026 owing to growing awareness related to early detection of cancer and high unmet diagnostic needs in the region. In addition, the presence of technologically advanced infrastructure for cancer care and increasing market penetration rates are other factors responsible for the regional market growth.
COVID-19 Impact
The COVID-19 pandemic has progressively impacted the global circulating tumor cells market. Increasing morbidity and mortality rates due to cancer around the world is grabbing the attention of circulating tumor cells for the detection of cancer. The industry players are increasingly investing in R&D activities for cell-based research as people suffering from chronic diseases are more prone to caught COVID-19 disease. Moreover, the high usage rates of CTC technologies in cancer detection and biotechnology research developments are helping the overall market to sustain in these pandemic stress.
Key Vendor Takeaway
The leading players of the global circulating tumor cells market include Greiner Bio-One International GmbH, Bio-Techne Corporation, QIAGEN, Menarini Silicon Biosystems, Biocept, Inc., Sysmex Corporation, BioFluidica, ScreenCell, Rarecells Diagnostics, Fluxion Biosciences, Inc., Miltenyi Biotec, Precision for Medicine, ApoCell, Inc., Aviva Biosciences, BioCep, Ltd., Ikonysis, Inc., IVDiagnostics, NanoString Technologies, Inc., Canopus Bioscience Ltd., Biolidics Limited, Creatv MicroTech, Inc., LungLife AI, Inc., Epic Sciences, ScreenCell, Vitatex, Inc., Rarecells Diagnostics, and Bio-Techne Corporation.
These players are adopting several strategies such as partnerships, mergers & acquisitions, and collaborations to hold a strong position in the global industry. For instance, in March 2020, ANGLE PLC and BioView Ltd. entered into a collaboration to develop an integrated workflow for detecting clinical biomarkers on CTCs at the Molecular Med Tri-Con Conference held in San Francisco.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2015 to2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2026
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CIRCULATING TUMOR CELLS MARKET PLAYERS
- ApoCell, Inc.
- Aviva Biosciences
- BioCep, Ltd.
- Ikonysis, Inc.
- QIAGEN
- Menarini Silicon Biosystems
- Biocept, Inc.
- Sysmex Corporation
- BioFluidica
- ScreenCell
- Fluxion Biosciences, Inc.
- Miltenyi Biotec
- Precision for Medicine
- ScreenCell
- Vitatex, Inc.
- Rarecell Diagnostics
- IVDiagnostics
- NanoString Technologies, Inc.
- Canopus Bioscience Ltd.
- Biolidics Limited
- Creatv MicroTech, Inc.
- LungLife AI, Inc.
- Epic Sciences
- Greiner Bio One International GmbH
- Bio-Techne Corporation
- Bio-Techne Corporation
GLOBAL CIRCULATING TUMOR CELLS MARKET, BY TECHNOLOGY
- CTC Analysis
- CTC Direct Detection Methods
- Microscopy
- SERS
- Others
- CTC Detection & Enrichment Methods
- Combined Methods
- Density-based Separation (Label-free)
- Size-based Separation (Label-free)
- Membrane-based
- Microfluidic-based
- Immunocapture (Label-based)
- Positive Selection
- Negative Selection
GLOBAL CIRCULATING TUMOR CELLS MARKET, BY APPLICATION
- Clinical/Liquid Biopsy
- Screening and Monitoring
- Risk Assessment
- Research
- Drug/Therapy Development
- Cancer Stem Cell & Tumorigenesis Research
GLOBAL CIRCULATING TUMOR CELLS MARKET, BY PRODUCT
- Kits & Reagents
- Devices or Systems
- Blood Collection Tubes
GLOBAL CIRCULATING TUMOR CELLS MARKET, BY SPECIMEN
- Blood
- Bone Marrow
- Other Body Fluids
GLOBAL CIRCULATING TUMOR CELLS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. CIRCULATING TUMOR CELLS MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Technology
2.1.2. Market Snippet by Application
2.1.3. Market Snippet by Product
2.1.4. Market Snippet by Specimen
2.1.5. Market Snippet by Region
2.2. Competitive Insights
3. CIRCULATING TUMOR CELLS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. CIRCULATING TUMOR CELLS INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
4.5. COVID-19 Impact Analysis
4.5.1. Pre-COVID-19 Impact Analysis
4.5.2. Post-COVID-19 Impact Analysis
5. CIRCULATING TUMOR CELLS MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. CIRCULATING TUMOR CELLS MARKET – BY TECHNOLOGY
6.1. Overview
6.1.1. Segment Share Analysis, By Technology, 2019 & 2026 (%)
6.2. CTC Analysis
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3. CTC Direct Detection Methods
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.2.1. Microscopy
6.3.2.1.1. Overview
6.3.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.2.2. SERS
6.3.2.2.1. Overview
6.3.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.2.3. Others
6.3.2.3.1. Overview
6.3.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4. CTC Detection & Enrichment Methods
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4.2.1. Combined Methods
6.4.2.1.1. Overview
6.4.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4.2.2. Density-based Separation (Label-free)
6.4.2.2.1. Overview
6.4.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4.2.3. Size-based Separation (Label-free)
6.4.2.3.1. Overview
6.4.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4.2.3.2.1. Membrane-based
6.4.2.3.2.1.1. Overview
6.4.2.3.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4.2.3.2.2. Microfluidic-based
6.4.2.3.2.2.1. Overview
6.4.2.3.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4.2.4. Immunocapture (Label-based)
6.4.2.4.1. Overview
6.4.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4.2.4.2.1. Positive Selection
6.4.2.4.2.1.1. Overview
6.4.2.4.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4.2.4.2.2. Negative Selection
6.4.2.4.2.2.1. Overview
6.4.2.4.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7. CIRCULATING TUMOR CELLS MARKET – BY APPLICATION
7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
7.2. Research
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.2.2.1. Drug/Therapy Development
7.2.2.1.1. Overview
7.2.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.2.2.2. Cancer Stem Cell & Tumorigenesis Research
7.2.2.2.1. Overview
7.2.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3. Clinical/Liquid Biopsy
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3.2.1. Screening and Monitoring
7.3.2.1.1. Overview
7.3.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3.2.2. Risk Assessment
7.3.2.2.1. Overview
7.3.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8. CIRCULATING TUMOR CELLS MARKET – BY PRODUCT
8.1. Overview
8.1.1. Segment Share Analysis, By Product, 2019 & 2026 (%)
8.2. Devices or Systems
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3. Blood Collection Tubes
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4. Kits & Reagents
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9. CIRCULATING TUMOR CELLS MARKET – BY SPECIMEN
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2019 & 2026 (%)
9.2. Bone Marrow
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.3. Blood
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.4. Other Body Fluids
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10. CIRCULATING TUMOR CELLS MARKET– BY GEOGRAPHY
10.1. Introduction
10.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
10.2. North America
10.2.1. Overview
10.2.2. Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.2.4. North America Market Size and Forecast, By Technology, 2015 – 2026 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
10.2.6. North America Market Size and Forecast, By Product, 2015 – 2026 (US$ Million)
10.2.7. North America Market Size and Forecast, By Specimen, 2015 – 2026 (US$ Million)
10.2.8. U.S.
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.2.9. Canada
10.2.9.1. Overview
10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Technology, 2015 – 2026 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Product, 2015 – 2026 (US$ Million)
10.3.7. Europe Market Size and Forecast, By Specimen, 2015 – 2026 (US$ Million)
10.3.8. Germany
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.10. United Kingdom
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.11. France
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.12. Rest of Europe
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2015 – 2026 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Product, 2015 – 2026 (US$ Million)
10.4.7. Asia Pacific Market Size and Forecast, By Specimen, 2015 – 2026 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.9. China
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.11. South Korea
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.12. Rest of APAC
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Technology, 2015 – 2026 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Product, 2015 – 2026 (US$ Million)
10.5.7. Latin America Market Size and Forecast, By Specimen, 2015 – 2026 (US$ Million)
10.5.8. Brazil
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5.9. Mexico
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5.10. Argentina
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2015 – 2026 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Product, 2015 – 2026 (US$ Million)
10.6.7. Middle East and Africa Market Size and Forecast, By Specimen, 2015 – 2026 (US$ Million)
10.6.8. Saudi Arabia
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.6.9. United Arab Emirates
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
11. KEY VENDOR ANALYSIS
11.1. Bio-Techne Corporation
11.1.1. Company Snapshot
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiatives
11.2. Biocept, Inc.
11.3. Sysmex Corporation
11.4. Greiner Bio One International GmbH
11.5. Precision for Medicine
11.6. ApoCell, Inc.
11.7. Aviva Biosciences
11.8. BioCep, Ltd.
11.9. Ikonysis, Inc.
11.10. IVDiagnostics
11.11. NanoString Technologies, Inc.
11.12. Canopus Bioscience Ltd.
11.13. Biolidics Limited
11.14. Creatv MicroTech, Inc.
11.15. LungLife AI, Inc.
11.16. BioFluidica
11.17. Rarecells Diagnostics
11.18. Fluxion Biosciences, Inc.
11.19. Miltenyi Biotec
11.20. QIAGEN
11.21. Menarini Silicon Biosystems
11.22. Epic Sciences
11.23. ScreenCell
11.24. Vitatex, Inc.
11.25. Rarecells Diagnostics
11.26. Bio-Techne Corporation
12. 360 DEGREE ANALYSTVIEW
13. APPENDIX
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Circulating Tumor Cells market: Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Technology
TABLE Global Circulating Tumor Cells market, by Technology 2015-2026 (USD Million)
TABLE Circulating Tumor Cells market: Application Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Circulating Tumor Cells market, by Application 2015-2026 (USD Million)
TABLE Circulating Tumor Cells market: Product Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Product
TABLE Global Circulating Tumor Cells market, by Product 2015-2026 (USD Million)
TABLE Circulating Tumor Cells market: Specimen Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Specimen
TABLE Global Circulating Tumor Cells market, by Specimen 2015-2026 (USD Million)
TABLE Circulating Tumor Cells market: Regional Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Circulating Tumor Cells market, by Region 2015-2026 (USD Million)
TABLE North America Circulating Tumor Cells market, by Country, 2015-2026 (USD Million)
TABLE North America Circulating Tumor Cells market, by Technology, 2015-2026 (USD Million)
TABLE North America Circulating Tumor Cells market, by Application, 2015-2026 (USD Million)
TABLE North America Circulating Tumor Cells market, by Product, 2015-2026 (USD Million)
TABLE North America Circulating Tumor Cells market, by Specimen, 2015-2026 (USD Million)
TABLE Europe Circulating Tumor Cells market, by Country, 2015-2026 (USD Million)
TABLE Europe Circulating Tumor Cells market, by Technology, 2015-2026 (USD Million)
TABLE Europe Circulating Tumor Cells market, by Application, 2015-2026 (USD Million)
TABLE Europe Circulating Tumor Cells market, by Product, 2015-2026 (USD Million)
TABLE Europe Circulating Tumor Cells market, by Specimen, 2015-2026 (USD Million)
TABLE Asia Pacific Circulating Tumor Cells market, by Country, 2015-2026 (USD Million)
TABLE Asia Pacific Circulating Tumor Cells market, by Technology, 2015-2026 (USD Million)
TABLE Asia Pacific Circulating Tumor Cells market, by Application, 2015-2026 (USD Million)
TABLE Asia Pacific Circulating Tumor Cells market, by Product, 2015-2026 (USD Million)
TABLE Asia Pacific Circulating Tumor Cells market, by Specimen, 2015-2026 (USD Million)
TABLE Latin America Circulating Tumor Cells market, by Country, 2015-2026 (USD Million)
TABLE Latin America Circulating Tumor Cells market, by Technology, 2015-2026 (USD Million)
TABLE Latin America Circulating Tumor Cells market, by Application, 2015-2026 (USD Million)
TABLE Latin America Circulating Tumor Cells market, by Product, 2015-2026 (USD Million)
TABLE Latin America Circulating Tumor Cells market, by Specimen, 2015-2026 (USD Million)
TABLE Middle East and Africa Circulating Tumor Cells market, by Country, 2015-2026 (USD Million)
TABLE Middle East and Africa Circulating Tumor Cells market, by Technology, 2015-2026 (USD Million)
TABLE Middle East and Africa Circulating Tumor Cells market, by Application, 2015-2026 (USD Million)
TABLE Middle East and Africa Circulating Tumor Cells market, by Product, 2015-2026 (USD Million)
TABLE Middle East and Africa Circulating Tumor Cells market, by Specimen, 2015-2026 (USD Million)
List of Figures
FIGURE Circulating Tumor Cells market segmentation
FIGURE Market Research Methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Technology segment market share analysis, 2019 & 2026
FIGURE Technology segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE CTC Analysis market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE CTC Direct Detection Methods market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Microscopy market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE SERS market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE CTC Detection & Enrichment Methods market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Combined Methods market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Density-based Separation (Label-free) market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Size-based Separation (Label-free) market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Membrane-based market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Microfluidic-based market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Immunocapture (Label-based) market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Positive Selection market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Negative Selection market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Application segment market share analysis, 2019 & 2026
FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Research market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Drug/Therapy Development market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Cancer Stem Cell & Tumorigenesis Research market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Clinical/Liquid Biopsy market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Screening and Monitoring market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Risk Assessment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Product segment market share analysis, 2019 & 2026
FIGURE Product segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Devices or Systems market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Blood Collection Tubes market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Kits & Reagents market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Specimen segment market share analysis, 2019 & 2026
FIGURE Specimen segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Bone Marrow market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Blood market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Other Body Fluids market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Regional segment market share analysis, 2019 & 2026
FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE North America Circulating Tumor Cells market share and leading players, 2018
FIGURE Europe Circulating Tumor Cells market share and leading players, 2018
FIGURE Asia Pacific Circulating Tumor Cells market share and leading players, 2018
FIGURE Latin America Circulating Tumor Cells market share and leading players, 2018
FIGURE Middle East and Africa Circulating Tumor Cells market share and leading players, 2018
FIGURE North America Circulating Tumor Cells market share analysis by country, 2018
FIGURE U.S. Circulating Tumor Cells Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Canada Circulating Tumor Cells Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Europe Circulating Tumor Cells Market share analysis by country, 2018
FIGURE Germany Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Spain Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Italy Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE UK Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE France Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of the Europe Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Asia Pacific Circulating Tumor Cells market share analysis by country, 2018
FIGURE India Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE China Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Japan Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE South Korea Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Singapore Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of APAC Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Circulating Tumor Cells market share analysis by country, 2018
FIGURE Brazil Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Mexico Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Argentina Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of LATAM Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Circulating Tumor Cells market share analysis by country, 2018
FIGURE Saudi Arabia Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE United Arab Emirates Circulating Tumor Cells market size, forecast and trend analysis, 2015 to 2026 (USD Million)
